According to the UnivDatos, the growing awareness of generic medicines in the region will drive the scenario of Generic Oncology Drugs and as per their “ MENA Generic Oncology Drug Market ” report, the MENA Market was valued at USD ~4 billion in 2022, growing at a CAGR of 3% during the forecast period from 2024 - 2032 to reach USD billion by 2030. The Middle East and North Africa...